child after receiving covid-19 vaccine at Austin Regional Clinic

COVID-19 vax scheduling open for children 6 mo-5 yrs

ARC has sufficient vaccine from both manufacturers for all pediatric patients at all primary care locations and encourages parents to get their infants 6 months and older immunized, in addition to children ages 5-17 for whom vaccinations are available, and boosters as recommended by the CDC. Vaccinations are also available in the five ARC After-Hours locations.

Patients may schedule by phone and online:

  • Parents/Guardians with proxy can schedule through ARC MyChart
  • If parent does not yet have proxy for their child/children, they should visit ARCMyChartproxy.com
  • Those without MyChart can call the ARC COVID-19 Hotline, 866-453-4525, or any ARC primary care location and press 1.

“I have seen so many parents who are anxious to get their youngest children vaccinated so they can join older siblings and friends in school, daycare, and activities,” said Elizabeth Knapp, MD, Co-Chief of ARC Pediatrics. “Even though the risk for COVID-19 infection is not as high as an adult risk, it’s not zero, and vaccination certainly helps protect against severe illness and hospitalization.”

Visit the ARC website, www.austinregionalclinic.com or log in to ARC MyChart for updates, or follow ARC on social media - Facebook, Twitter, and Instagram.

Tags: COVID-19

More on this Topic

What illnesses are children catching this fall?

Elizabeth C. Knapp, MD, Pediatrician at ARC Far West, addresses the illnesses that ARC Pediatricians have been seeing this fall. See what’s going around.

FDA and CDC authorize COVID-19 booster for omicron variant

ARC is awaiting our Omicron Booster vaccine shipment. Schedules will be open at MyChartARC.com as soon as we receive vaccine. Read more.

ARC enrolling for COVID-19 variants vaccine trial

ARC is currently enrolling participants in a study testing an “updated” vaccine targeting specific variants. Learn more.

What have we learned in two years of COVID-19?

Anas Daghestani, MD, ARC CEO, and Amy B. Siegel, MD, ARC Internal Medicine and ARC Clinical Researcher, share their thoughts and lessons from the last two years of the pandemic in this recent article.

FDA approves first COVID treatment pill

This week, the Food and Drug Administration authorized the first antiviral pill, Paxlovid, to treat COVID-19 at home. Learn more.